Your browser doesn't support javascript.
loading
Distinct roles of the preparatory and payoff phases of glycolysis in hematopoietic stem cells.
Shiroshita, Kohei; Kobayashi, Hiroshi; Watanuki, Shintaro; Karigane, Daiki; Sorimachi, Yuriko; Tamaki, Shinpei; Haraguchi, Miho; Yamamoto, Masamichi; Nakamura-Ishizu, Ayako; Okamoto, Shinichiro; Kataoka, Keisuke; Takubo, Keiyo.
Afiliación
  • Shiroshita K; Department of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Kobayashi H; Department of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
  • Watanuki S; Department of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Karigane D; Department of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Sorimachi Y; Department of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
  • Tamaki S; Department of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
  • Haraguchi M; Department of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
  • Yamamoto M; Department of Research Promotion and Management, National Cerebral and Cardiovascular Center, Osaka, Japan.
  • Nakamura-Ishizu A; Department of Microscopic and Developmental Anatomy, Tokyo Women's Medical University, Tokyo, Japan.
  • Okamoto S; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Kataoka K; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.
  • Takubo K; Department of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: keiyot@gmail.com.
Exp Hematol ; 124: 56-67, 2023 08.
Article en En | MEDLINE | ID: mdl-37339713
ABSTRACT
In physiological conditions, most adult hematopoietic stem cells (HSCs) maintain a quiescent state. Glycolysis is a metabolic process that can be divided into preparatory and payoff phases. Although the payoff phase maintains HSC function and properties, the role of the preparatory phase remains unknown. In this study, we aimed to investigate whether the preparatory or payoff phases of glycolysis were required for maintenance of quiescent and proliferative HSCs. We used glucose-6-phosphate isomerase (Gpi1) as a representative gene for the preparatory phase and glyceraldehyde-3-phosphate dehydrogenase (Gapdh) as a representative gene for the payoff phase of glycolysis. First, we identified that stem cell function and survival were impaired in Gapdh-edited proliferative HSCs. Contrastingly, cell survival was maintained in quiescent Gapdh- and Gpi1-edited HSCs. Gapdh- and Gpi1-defective quiescent HSCs maintained adenosine-triphosphate (ATP) levels by increasing mitochondrial oxidative phosphorylation (OXPHOS), whereas ATP levels were decreased in Gapdh-edited proliferative HSCs. Interestingly, Gpi1-edited proliferative HSCs maintained ATP levels independent of increased OXPHOS. Oxythiamine, a transketolase inhibitor, impaired proliferation of Gpi1-edited HSCs, suggesting that the nonoxidative pentose phosphate pathway (PPP) is an alternative means to maintain glycolytic flux in Gpi1-defective HSCs. Our findings suggest that OXPHOS compensated for glycolytic deficiencies in quiescent HSCs, and that in proliferative HSCs, nonoxidative PPP compensated for defects in the preparatory phase of glycolysis but not for defects in the payoff phase. These findings provide new insights into regulation of HSC metabolism, which could have implications for development of novel therapies for hematologic disorders.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Células Madre Hematopoyéticas / Glucólisis Tipo de estudio: Prognostic_studies Idioma: En Revista: Exp Hematol Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Células Madre Hematopoyéticas / Glucólisis Tipo de estudio: Prognostic_studies Idioma: En Revista: Exp Hematol Año: 2023 Tipo del documento: Article